2000-Year of the Biotechs! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2000-Year of the Biotechs!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (247)	2/8/2000 10:20:00 AM
From: Jack Hartmann	Read Replies (2) of 1142

SCLN has two promising products Zadaxin and CPX. Zadaxin is an immune system booster which they are using for Hepatitis C and B and it's generating revenues for them abroad. CPX is their hope for a cure for cystic fibrosis. Phase 2 may be completed this spring. They 8 straight quarters of revenue growth and last year grew revenues at 150%. They are looking to be profitable in the last quater of year 2000. Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next